Elizabeth Buck's most recent trade in Black Diamond Therapeutics Inc was a trade of 175,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Black Diamond Therapeutics... | Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2025 | 75,000 | 170,192 (0%) | 0% | 0 | Common Stock | |
| Black Diamond Therapeutics... | Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics... | Elizabeth Buck | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) |